The Nation - News from Dec. 13, 1985
Upjohn Co. of Kalamazoo, Mich., has completed testing of a drug touted as a cure for baldness and this month will ask the U.S. Food and Drug Administration to approve prescription sales of the drug, the company said. Under the name Loniten, the drug has been prescribed for years to control high blood pressure. As a baldness cure, it will be called Minoxil. “It’s still experimental,” said Jan Ausderheide, an Upjohn spokeswoman. It takes the FDA about two years to decide, she noted.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
